Table 2.
Individual Patient Characteristics
| Age, y | Sex (M/F) | Thrombus Location | Etiology | Time From Onset of Symptoms to Diagnosis (h) | Time From Diagnosis to Intervention (h) | Thrombectomy Devices | mTICI | Complication | Antithrombotic Treatment | PedNIHSS Before Procedure | PedNIHSS After 12 ‐24 h | PedNIHSS After 7 d | ASPECTS (pre/post) | mRS (3 mo) | PSOM (3 mo) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Center 1: Muenster | |||||||||||||||
| 7 | M | M2 | Complex cardiac anomaly | 1.5 | 0.5 |
Stent retriever: Preset 4×20 mm, sheath: 5F Microcatheter: 2.4F |
2b | Spasms, resolved after administration of nimodipine | Preexisting warfarin, peri‐interventional Clexane | 33 | 10 | 9 | 10/8 | 2 | 3 |
| 7 | F | Carotid‐T | Complex cardiac anomality | 2 | 1 |
Stent retriever: Preset 4×20 mm, sheath: 5F Microcatheter: 2.4F |
3 | None | Preexisting Warfarin, peri‐interventional Clexane | 35 | 8 | 5 | 8/8 | 2 | 2 |
| 14 | M | Carotid‐T | FCAi | 3 (started with fluctuating symptoms 12 h earlier) | 1 |
Stent retriever: Preset 4×20 mm, sheath: 5F Microcatheter: 2.4F |
3 | Spasms, resolved after administration of nimodipine | Clexane after thrombectomy | 5 | 0 | 0 | 9/9 | 0 | 0 |
| 15 | F | M1 | FCAi | 1.5 | 0.5 |
Stent retriever: Preset 4×20 mm, sheath: 8F Microcatheter: 2.8F |
2b | None | Clexane after thrombectomy | 20 | 5 | 5 | 8/7 | 1 | 2 |
| 15 | F | M1 | Complex cardiac anomality | 2 | 0.5 |
Stent retriever: Preset 4×20 mm, sheath: 6F Microcatheter: 2.4F |
3 | None | Preexisting warfarin, peri‐interventional Clexane | 22 | 7 | 4 | 8/8 | 1 | 1 |
| Center 2: Hamburg | |||||||||||||||
| 10 | F | M1 | Complex cardiac anomality | 0.5 | 0.5 |
Stent retriever: Solitaire 4×20 mm, sheath: 5F+5F aspiration catheter Microcatheter: 2.4F |
2b | None | Preexisting warfarin, peri‐interventional Clexane | 8 | 1 | 1 | 7/7 | 0 | 0 |
| 16 | M | M1 | Fibromuscular dysplasia | 3 | 0.5 |
Stent retriever: Solitaire 4×20 mm, sheath: 5F+5F aspiration catheter Microcatheter: 2.4F |
3 | None | None | 3 | 1 | 1 | 8/8 | 0 | 0 |
| 16 | F | M1 | Secondary vasculitis after meningitis | 1 | 1 |
Stent retriever: Solitaire 4×20 mm, sheath: 5F+5F aspiration catheter Microcatheter: 2.4F |
2b | None | None | 13 | 10 | 10 | 6/6 | 2 | 3 |
| 17 | F | M1 | Sepsis‐associated coagulopathy | 0.5 | 0.5 |
Stent retriever: Solitaire 4×20 mm, sheath: 5F+5F aspiration catheter. Microcatheter: 2.4F |
3 | None | Clexane after thrombectomy | 14 | 3 | 3 | 8/8 | 0 | 0 |
| 17 | M | M1 | Thalassemia | 1.5 | 0.5 |
Stent retriever: Solitaire 4×20 mm, sheath: 5F+5F aspiration catheter. Microcatheter: 2.4F |
2b | None | Clexane after thrombectomy | 8 | 1 | 1 | 6/6 | 0 | 0 |
| Center 3 Lübeck | |||||||||||||||
| 5 | M | M1 | Complex cardiac anomaly | 1.5 | 0.5 |
Stent retriever: Trevo 4×20 mm, sheath: 5F+5F aspiration catheter Microcatheter: 2.4F |
2b | None | Preexisting warfarin, peri‐interventional Clexane | 10 | 5 | 15 | 10/2 (secondary event right MCA) | 3 | 5 |
| 10 | M | M1 | Dissection | 1.5 | 0.5 |
Stent retriever: Trevo 4×20 mm, sheath: 5F+5F aspiration catheter Microcatheter: 2.4F |
3 | None | Clexane after thrombectomy | 12 | 3 | 3 | 7/7 | 1 | 1 |
ASPECTS indicates Alberta Stroke Program Early Computed Tomography Score; FCAi, focal cerebral arteriopathy of inflammatory subtype; carotid T, internal carotid artery; MCA, middle cerebral artery; mRS, modified Rankin Scale; mTICI, modified Treatment in Cerebral Infarction Score; PedNIHSS, Pediatric National Institutes of Health Stroke Scale; pre, on admission; post, 12‐24 hours after admission; PSOM, pediatric stroke outcome measure.